NAVB Research and Charts

NAVB - Navidea Biopharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2024-12-31)

Last 0.00	Change ⇓ 0.00 (0.00%)	Volume 118,879
	Open 0.00	High 0.00	Low 0.00

8EMA (Daily) 0.00	40EMA (Daily) 0.00	50EMA (Daily) 0.00	STO (Daily) 0.000	MACD Hist (Daily) 0.000
8EMA (Weekly) 0.000	40EMA (Weekly) 0.01	50EMA (Weekly) 0.03	STO (Weekly) 0.000	MACD Hist (Weekly) 0.004


Company Profile
Navidea Biopharmaceuticals Inc is a biotechnology company specialized in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.